Silencing HK3 curbs lactate-driven histone lactylation, switches macrophage polarity, and dampens synovial fibroblast invasion; consequently, it has been prioritized for mechanistic dissection and therapeutic targeting in RA [33,34]. The gene discussed is HK3; the disease is rheumatoid arthritis.